139 related articles for article (PubMed ID: 32037578)
1. Technical Note: Benchmarking automated eye tracking and human detection for motion monitoring in ocular proton therapy.
Via R; Hennings F; Fattori G; Pica A; Lomax A; Weber DC; Baroni G; Hrbacek J
Med Phys; 2020 Jun; 47(5):2237-2241. PubMed ID: 32037578
[TBL] [Abstract][Full Text] [Related]
2. Noninvasive eye localization in ocular proton therapy through optical eye tracking: A proof of concept.
Via R; Hennings F; Fattori G; Fassi A; Pica A; Lomax A; Weber DC; Baroni G; Hrbacek J
Med Phys; 2018 May; 45(5):2186-2194. PubMed ID: 29493800
[TBL] [Abstract][Full Text] [Related]
3. Optical eye tracking system for real-time noninvasive tumor localization in external beam radiotherapy.
Via R; Fassi A; Fattori G; Fontana G; Pella A; Tagaste B; Riboldi M; Ciocca M; Orecchia R; Baroni G
Med Phys; 2015 May; 42(5):2194-202. PubMed ID: 25979013
[TBL] [Abstract][Full Text] [Related]
4. A noninvasive eye fixation and computer-aided eye monitoring system for linear accelerator-based stereotactic radiotherapy of uveal melanoma.
Bogner J; Petersch B; Georg D; Dieckmann K; Zehetmayer M; Pötter R
Int J Radiat Oncol Biol Phys; 2003 Jul; 56(4):1128-36. PubMed ID: 12829151
[TBL] [Abstract][Full Text] [Related]
5. Practice Patterns Analysis of Ocular Proton Therapy Centers: The International OPTIC Survey.
Hrbacek J; Mishra KK; Kacperek A; Dendale R; Nauraye C; Auger M; Herault J; Daftari IK; Trofimov AV; Shih HA; Chen YE; Denker A; Heufelder J; Horwacik T; Swakoń J; Hoehr C; Duzenli C; Pica A; Goudjil F; Mazal A; Thariat J; Weber DC
Int J Radiat Oncol Biol Phys; 2016 May; 95(1):336-343. PubMed ID: 27084651
[TBL] [Abstract][Full Text] [Related]
6. Comparison between patient-reported outcomes after enucleation and proton beam radiotherapy for uveal melanomas: a 2-year cohort study.
Hope-Stone L; Brown SL; Heimann H; Damato B
Eye (Lond); 2019 Sep; 33(9):1478-1484. PubMed ID: 30988421
[TBL] [Abstract][Full Text] [Related]
7. Linear accelerator-based stereotactic fractionated photon radiotherapy as an eye-conserving treatment for uveal melanoma.
Akbaba S; Foerster R; Nicolay NH; Arians N; Bostel T; Debus J; Hauswald H
Radiat Oncol; 2018 Aug; 13(1):140. PubMed ID: 30071857
[TBL] [Abstract][Full Text] [Related]
8. Automatic real-time surveillance of eye position and gating for stereotactic radiotherapy of uveal melanoma.
Petersch B; Bogner J; Dieckmann K; Pötter R; Georg D
Med Phys; 2004 Dec; 31(12):3521-7. PubMed ID: 15651635
[TBL] [Abstract][Full Text] [Related]
9. Proton therapy for uveal melanomas and other eye lesions.
Munzenrider JE
Strahlenther Onkol; 1999 Jun; 175 Suppl 2():68-73. PubMed ID: 10394402
[TBL] [Abstract][Full Text] [Related]
10. Neoadjuvant proton beam irradiation vs. adjuvant ruthenium brachytherapy in transscleral resection of uveal melanoma.
Böker A; Pilger D; Cordini D; Seibel I; Riechardt AI; Joussen AM; Bechrakis NE
Graefes Arch Clin Exp Ophthalmol; 2018 Sep; 256(9):1767-1775. PubMed ID: 29907945
[TBL] [Abstract][Full Text] [Related]
11. Estimates of ocular and visual retention following treatment of extra-large uveal melanomas by proton beam radiotherapy.
Conway RM; Poothullil AM; Daftari IK; Weinberg V; Chung JE; O'Brien JM
Arch Ophthalmol; 2006 Jun; 124(6):838-43. PubMed ID: 16769837
[TBL] [Abstract][Full Text] [Related]
12. Outcomes of treatment with stereotactic radiosurgery or proton beam therapy for choroidal melanoma.
Sikuade MJ; Salvi S; Rundle PA; Errington DG; Kacperek A; Rennie IG
Eye (Lond); 2015 Sep; 29(9):1194-8. PubMed ID: 26160531
[TBL] [Abstract][Full Text] [Related]
13. Automated Treatment Planning System for Uveal Melanomas Treated With Proton Therapy: A Proof-of-Concept Analysis.
Hennings F; Lomax A; Pica A; Weber DC; Hrbacek J
Int J Radiat Oncol Biol Phys; 2018 Jul; 101(3):724-731. PubMed ID: 29893280
[TBL] [Abstract][Full Text] [Related]
14. A linac-based stereotactic irradiation technique of uveal melanoma.
Dieckmann K; Bogner J; Georg D; Zehetmayer M; Kren G; Pötter R
Radiother Oncol; 2001 Oct; 61(1):49-56. PubMed ID: 11578728
[TBL] [Abstract][Full Text] [Related]
15. Intravitreal bevacizumab for neovascular glaucoma in uveal melanoma treated by proton beam therapy.
Mahdjoubi A; Najean M; Lemaitre S; Dureau S; Dendale R; Levy C; Rouic LL; Desjardins L; Cassoux N
Graefes Arch Clin Exp Ophthalmol; 2018 Feb; 256(2):411-420. PubMed ID: 29116399
[TBL] [Abstract][Full Text] [Related]
16. [Endoresection following proton beam irradiation of large uveal melanomas].
Bechrakis NE; Höcht S; Martus P; Kreusel KM; Heese J; Foerster MH
Ophthalmologe; 2004 Apr; 101(4):370-6. PubMed ID: 15067418
[TBL] [Abstract][Full Text] [Related]
17. A platform for patient positioning and motion monitoring in ocular proton therapy with a non-dedicated beamline.
Via R; Pella A; Romanò F; Fassi A; Ricotti R; Tagaste B; Vai A; Mastella E; Rosaria Fiore M; Valvo F; Ciocca M; Baroni G
Phys Med; 2019 Mar; 59():55-63. PubMed ID: 30928066
[TBL] [Abstract][Full Text] [Related]
18. Combined proton beam radiotherapy and transpupillary thermotherapy for large uveal melanomas: a randomized study of 151 patients.
Desjardins L; Lumbroso-Le Rouic L; Levy-Gabriel C; Dendale R; Delacroix S; Nauraye C; Estève M; Plancher C; Asselain B
Ophthalmic Res; 2006; 38(5):255-60. PubMed ID: 16888407
[TBL] [Abstract][Full Text] [Related]
19. Intraocular inflammation after proton beam irradiation for uveal melanoma.
Lumbroso L; Desjardins L; Levy C; Plancher C; Frau E; D'Hermies F; Schlienger P; Mammar H; Delacroix S; Nauraye C; Ferrand R; Desblancs C; Mazal A; Asselain B
Br J Ophthalmol; 2001 Nov; 85(11):1305-8. PubMed ID: 11673294
[TBL] [Abstract][Full Text] [Related]
20. Fractionated stereotactic radiotherapy with linear accelerator for uveal melanoma--preliminary Vienna results.
Zehetmayer M; Dieckmann K; Kren G; Kitz K; Ruhswurm I; Georgopoulos M; Pötter R
Strahlenther Onkol; 1999 Jun; 175 Suppl 2():74-5. PubMed ID: 10394403
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
